NASDAQ: CARMCarisma Therapeutics Inc Stock Ownership - Who owns Carisma Therapeutics?
Insider buying vs selling
Have Carisma Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CARM insiders and whales buy or sell their stock.
CARM Shareholders
What type of owners hold Carisma Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Modernatx Inc | 12.11% | 5,059,338 | $971.39k | Insider |
| Third Rock Ventures LP | 11.59% | 4,841,591 | $929.59k | Insider |
| Leslie Dan | 8.57% | 3,582,328 | $687.81k | Insider |
| Clairmark Investments Ltd | 8.57% | 3,582,328 | $687.81k | Insider |
| Regina Hodits | 5.50% | 2,297,546 | $441.13k | Insider |
| Chidozie Ugwumba | 5.30% | 2,215,877 | $425.45k | Insider |
| Jafco Super V3 Investment Limited Partnership | 4.60% | 1,923,226 | $369.26k | Insider |
| Flagship Ventures Fund IV LP | 4.39% | 1,833,802 | $352.09k | Insider |
| Merck Co Inc | 3.53% | 1,473,240 | $282.86k | Institution |
| Vanguard Group Inc | 3.40% | 1,418,848 | $272.42k | Institution |
CARM vs Biotech Stocks
Carisma Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.